登录 注册 会员服务 联系我们

Nomogram for distant metastasis-free survival in patients with locoregionally advanced nasopharyngeal carcinoma

  • Published:2022-04-06 Issue:9 Volume:198 Page:828-837
  • ISSN:0179-7158
  • Container-title:Strahlentherapie und Onkologie
  • language:en
  • Short-container-title:Strahlenther Onkol

Author:

Yang Huiyun,Zhang Rongjun,Zhang Ruyun,Zhang Bin,Xie Yuan,Qin Guanjie,Mo Yunyan,Ruan Xiaolan,Jiang WeiORCID

Funder

National Natural Science Foundation of China

Scientific Research and Technology Development Program of Guilin

the General Program of Guangxi Natural Science Foundation of China

CSCO Youth Innovative Oncology Research Fund

Natural Science Foundation of Guangxi Province

the Key Research and Development Program of Guangxi

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Radiology, Nuclear Medicine and imaging

Reference41 articles.

1. Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H et al (2017) Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol 3(4):524–548. https://doi.org/10.1001/jamaoncol.2016.5688

2. Lee AW, Lau WH, Tung SY, Chua DT, Chappell R, Xu L et al (2005) Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group. J Clin Oncol 23(28):6966–6975. https://doi.org/10.1200/jco.2004.00.7542

3. Sun Y, Li WF, Chen NY, Zhang N, Hu GQ, Xie FY et al (2016) Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial. Lancet Oncol 17(11):1509–1520. https://doi.org/10.1016/s1470-2045(16)30410-7

4. Yang Q, Cao SM, Guo L, Hua YJ, Huang PY, Zhang XL et al (2019) Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial. Eur J Cancer 119:87–96. https://doi.org/10.1016/j.ejca .2019.07.007

5. Jin Y, Shi YX, Cai XY, Xia XY, Cai YC, Cao Y et al (2012) Comparison of five cisplatin-based regimens frequently used as the first-line protocols in metastatic nasopharyngeal carcinoma. J Cancer Res Clin Oncol 138(10):1717–1725. https://doi.org/10.1007/s00432-012-1219-x
同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3